GLR Partners, LLC

Position in BRNS — Barinthus Biotherapeutics plc.

CIK 2134831 COLUMBIA, MD

Position in BRNS

as of Jun 30, 2026 · filed Jul 27, 2026 Compact

Position Value

$820,628

+$113,147 QoQ

Shares Held

1,243,377

0.0% QoQ

Ownership

3.04%

of shares outstanding

% of Portfolio

0.88%

of 13F equity value

Holder Rank

of 1 holders

Holding Since

Mar 2026

2 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

GLR Partners, LLC holds $1,837,830 across 3 Biotechnology names. BRNS ranks #1 (44.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	BRNS	Barinthus Biotherapeutics plc. This page	1,243,377	$820,628
2	PGEN	Precigen, Inc.	140,169	$798,963
3	REGN	Regeneron Pharmaceuticals, Inc.	350	$218,239

2 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$820,628	1,243,377	0.0%	Shares	Sole	2026-07-27
2026-03-31	$707,481	1,243,377	—	Shares	Sole	2026-05-13
No filing history on record for this holder in this stock.